In a recent article published on Pharmaceutical Executive, we look at the Emergence of Cancer Vaccines: Reframing Value Demonstration, Pricing, and Access

The application of biomarkers in therapy areas beyond oncology will likely play an ever-crucial role in developing more targeted therapies in high unmet need indications, while providing payers with new attributes by which to assess a new treatment’s value.